Literature DB >> 9767427

Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.

L de Haan1, W R Verweij, I K Feil, M Holtrop, W G Hol, E Agsteribbe, J Wilschut.   

Abstract

Escherichia coli (E. coli) heat-labile toxin (LT) is a potent mucosal immunogen and immunoadjuvant towards co-administered antigens. LT is composed of one copy of the A subunit, which has ADP-ribosylation activity, and a homopentamer of B subunits, which has affinity for the toxin receptor, the ganglioside GM1. Both the ADP-ribosylation activity of LTA and GM1 binding of LTB have been proposed to be involved in immune stimulation. We investigated the roles of these activities in the immunogenicity of recombinant LT or LTB upon intranasal immunization of mice using LT/LTB mutants, lacking either ADP-ribosylation activity, GM1-binding affinity, or both. Likewise, the adjuvant properties of these LT/LTB variants towards influenza virus subunit antigen were investigated. With respect to the immunogenicity of LT and LTB, we found that GM1-binding activity is essential for effective induction of anti-LTB antibodies. On the other hand, an LT mutant lacking ADP-ribosylation activity retained the immunogenic properties of the native toxin, indicating that ADP ribosylation is not critically involved. Whereas adjuvanticity of LTB was found to be directly related to GM1-binding activity, adjuvanticity of LT was found to be independent of GM1-binding affinity. Moreover, a mutant lacking both GM1-binding and ADP-ribosylation activity, also retained adjuvanticity. These results demonstrate that neither ADP-ribosylation activity nor GM1 binding are essential for adjuvanticity of LT, and suggest an ADP-ribosylation-independent adjuvant effect of the A subunit.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767427      PMCID: PMC1364263          DOI: 10.1046/j.1365-2567.1998.00535.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.

Authors:  M T Dertzbaugh; C O Elson
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

2.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

3.  Use of substituted (benzylidineamino)guanidines in the study of guanidino group specific ADP-ribosyltransferase.

Authors:  G Soman; J Narayanan; B L Martin; D J Graves
Journal:  Biochemistry       Date:  1986-07-15       Impact factor: 3.162

4.  Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis.

Authors:  M G Jobling; R K Holmes
Journal:  Mol Microbiol       Date:  1991-07       Impact factor: 3.501

5.  Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

Review 6.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

Authors:  B D Spangler
Journal:  Microbiol Rev       Date:  1992-12

7.  Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

Authors:  J D Clements; N M Hartzog; F L Lyon
Journal:  Vaccine       Date:  1988-06       Impact factor: 3.641

8.  The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity.

Authors:  N Lycke; T Tsuji; J Holmgren
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

9.  Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin.

Authors:  J Holmgren; P Fredman; M Lindblad; A M Svennerholm; L Svennerholm
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.

Authors:  B L Dickinson; J D Clements
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more
  22 in total

1.  Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.

Authors:  A Bacon; J Makin; P J Sizer; I Jabbal-Gill; M Hinchcliffe; L Illum; S Chatfield; M Roberts
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.

Authors:  Jose Flores; Herbert L DuPont; Mercedes Paredes-Paredes; M Magdalena Aguirre-Garcia; Araceli Rojas; Alexei Gonzalez; Pablo C Okhuysen
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

3.  Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.

Authors:  Frederik W van Ginkel; Raymond J Jackson; Naoto Yoshino; Yukari Hagiwara; Daniel J Metzger; Terry D Connell; Hong L Vu; Michael Martin; Kohtaro Fujihashi; Jerry R McGhee
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Expression of a synthetic cholera toxin B subunit in tobacco using ubiquitin promoter and bar gene as a selectable marker.

Authors:  Tae-Jin Kang; Bang-Geul Kim; Ji-Yeon Yang; Moon-Sik Yang
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

5.  Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells.

Authors:  Alexandra Sherman; Jin Su; Shina Lin; Xiaomei Wang; Roland W Herzog; Henry Daniell
Journal:  Blood       Date:  2014-05-13       Impact factor: 22.113

6.  Functional diversity of heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli: differential enzymatic and immunological activities of LT1 (hLT) AND LT4 (pLT).

Authors:  Juliana F Rodrigues; Camila Mathias-Santos; Maria Elisabete Sbrogio-Almeida; Jaime H Amorim; Joaquim Cabrera-Crespo; Andrea Balan; Luís C S Ferreira
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

7.  An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants.

Authors:  Kenneth C Bagley; Sayed F Abdelwahab; Robert G Tuskan; George K Lewis
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.

Authors:  L De Haan; M Holtrop; W R Verweij; E Agsteribbe; J Wilschut
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

9.  Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway.

Authors:  Kenneth C Bagley; Sayed F Abdelwahab; Robert G Tuskan; Timothy R Fouts; George K Lewis
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.

Authors:  Tae-Geum Kim; Bang-Geul Kim; Mi-Young Kim; Jae-Kwon Choi; Eun-Sun Jung; Moon-Sik Yang
Journal:  Mol Biotechnol       Date:  2009-08-06       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.